NEWSROOM

April 17, 2024

Ad-hoc announcement pursuant to Art. 53 LR

SHL Announces Full-Year 2023 Results – Stable Revenue Growth Alongside Groundbreaking Clinical Milestones

April 11, 2024

Study shows groundbreaking final results for SHL Telemedicine’s SmartHeart® in Post-ACS patient care

April 8, 2024

SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment

April 5, 2024

SHL Telemedicine: Invitation to Conference Call Presenting Annual Results 2023

March 26, 2024

SHL announces invitation to a Special General Meeting

March 14, 2024

SHL Telemedicine receives buy rating with $11.00 price target

March 14, 2024

Ad-hoc announcement pursuant to Art. 53 LR

SHL announces change in CEO position

February 8, 2024

SHL announces Annual General Meeting Results

February 6, 2024

Ad-hoc announcement pursuant to Art. 53 LR

Update regarding upcoming Annual General Meeting – Change in theComposition of the Board of Directors